SCHEMBL5496398

SCHEMBL5496398

Brc1cnc(-c2ccsc2)cn1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 4/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ CYP2A6 P11509 8/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ SENP6 Q9GZR1 1/20 0.44
▸ CYP2B6 P20813 3/20 0.42
▸ CYP2E1 P05181 2/20 0.42
▸ CYP11B1 P15538 2/20 0.39
▸ CYP11B2 P19099 2/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ DYRK1B Q9Y463 1/20 0.39
▸ PDGFRB P09619 1/20 0.38
▸ PDGFRA P16234 1/20 0.38
▸ ATR Q13535 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12302110 0.77 CASP3 (0.47) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL2644971 0.77 FYN (0.47) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL31049776 0.77 FYN (0.49) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL31300151 0.74 CYP19A1 (0.46) FYNNPC1CYP11B1CYP11B2CYP3A4
SCHEMBL12248379 0.73 CYP11B1 (0.44) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL10328676 0.72 CSNK2A1 (0.42) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL29791128 0.71 CYP2A6 (0.43) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL12234576 0.71 MAPK1 (0.43) NPC1CYP11B1CYP11B2PDGFRB
SCHEMBL5349799 0.71 CYP2A6 (0.42) FYNNPC1CYP2A6CASP3SENP8
SCHEMBL9825891 0.71 CYP2A6 (0.53) FYNNPC1CYP2A6CASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 — — US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 — — US disclosed
US-20070293484-A1 Thiophene Heteroaryl Amines SUGEN, INC. 2007-12-20 — — US disclosed
EP-1753750-A1 THIOPHENE HETEROARYL AMINES Sugen, Inc. (US) 2007-02-21 — — EP disclosed
WO-2005113548-A1 THIOPHENE HETEROARYL AMINES SUGEN, INC. (US) 2005-12-01 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070293484-A1 Thiophene Heteroaryl Amines TTK, CHEK2, ABL1 FYN 310/4885NPC1 2133/4885CYP2A6 3815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback